Open AccessP380: EX VIVO IMMUNE ACTIVATION WITH THE MACROPHAGE‐TARGETING IMMUNOTHERAPY, ANTI‐CLEVER‐1 ANTIBODY BEXMARILIMAB, IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
Author(s) -
Aakko S.,
Ylitalo A.,
Kuusanmäki H.,
Björkman M.,
Mandelin J.,
Jalkanen J.,
Fjällskog M.L.,
Heckman C.,
Hollmén M.,
Kontro M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844408.27334.5c
Subject(s) - myeloid leukemia , medicine , immunotherapy , cancer research , myelodysplastic syndromes , venetoclax , myeloid , cd8 , immunology , leukemia , hematology , cancer , bone marrow , ex vivo , immune system , in vivo , biology , chronic lymphocytic leukemia , microbiology and biotechnology